Human Laminin 332 E8 Protein, recombinant

Human Laminin 332 E8 Protein, recombinant
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NOV-C28U.10ug 10 µg - -

10 - 15 business days*

38.00€
NOV-C28U.50ug 50 µg - -

10 - 15 business days*

113.00€
NOV-C28U.500ug 500 µg - -

10 - 15 business days*

813.00€
NOV-C28U.1mg 1 mg - -

10 - 15 business days*

1,138.00€
 
Recombinant Human Laminin 332 is produced by our Mammalian expression system and the target gene... more
Product information "Human Laminin 332 E8 Protein, recombinant"
Recombinant Human Laminin 332 is produced by our Mammalian expression system and the target gene encoding Pro699-Gln1348&Gln1062-Lys1172&Val1074-Gln1193 is expressed with a 6His, human IgG1 Fc and human IgG1 Fc tag at N terminus. Protein function: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. [The UniProt Consortium]
Keywords: E170, LAMA3, LAMNA, Nicein subunit alpha, Kalinin subunit alpha, Epiligrin subunit alpha, Laminin-6 subunit alpha, Laminin subunit alpha-3, Laminin-5 subunit alpha, Laminin-7 subunit alpha, Epiligrin 170 kDa subunit, Recombinant Human Laminin 332 E8 Prote
Supplier: Novoprotein
Supplier-Nr: C28U

Properties

Conjugate: No
Host: Human cells
Species reactivity: human
MW: 74/40/40 kD
Format: Solution

Database Information

KEGG ID : K06240 | Matching products
UniProt ID : Q16787 | Matching products

Handling & Safety

Storage: -80°C (avoid repeat freezing and thawing cycles)
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Human Laminin 332 E8 Protein, recombinant"
Write a review
or to review a product.
Viewed